Amaya Bélanger-Quintana

Author

Hospital Universitario Ramón y Cajal ORCID

Also Known As

A BELANGERQUINTANA, A Bélanger-Quintana, A. Belanger-Quintana, A. Belanger‐Quintana, A. Bélanger-Quintana, Amaya Belanger, Amaya Belanger-Quintana, Amaya Belanger‐Quintana, Amaya Bèlanger-Quintana, Amaya Bélanger-Quintana

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Ramón y Cajal Universidad Autónoma de Madrid Centro de Investigación Biomédica en Red University Medical Center Groningen University of Groningen

About

Amaya Bélanger-Quintana is an author at Hospital Universitario Ramón y Cajal specializing in medicine, chronic kidney disease, and nephrology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	711
2	Public Health	5	5	452
3	Clinical Nutrition	2	2	61
4	Health Sciences	1	1	18
5	Biochemistry	1	1	43

Amaya Bélanger-Quintana

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
The Genetic Landscape and Epidemiology of Phenylketonuria Alicia Hillert, Yair Anikster, Amaya Bélanger-Quintana, The American Journal of Human Genetics Genetic LandscapeGenetic DisorderMedicineGeneticsGenetic Epidemiology	2020	339
Blood phenylalanine control in phenylketonuria: a survey of 10 European centres Kirsten Ahring, Amaya Bélanger-Quintana, Katharina Dokoupil, European Journal of Clinical Nutrition UrologyMedicineChronic Kidney DiseaseBlood Phenylalanine ControlPharmacology	2010	66
Tetrahydrobiopterin responsiveness: results of the BH4 loading test in 31 Spanish PKU patients and correlation with their genotype Lourdes R. Desviat, Belén Pérez, Amaya Bélanger-Quintana, Molecular Genetics and Metabolism Inherited Metabolic DiseasePathologyTetrahydrobiopterin ResponsivenessSpanish Pku PatientsMedicine	2004	65
Special low protein foods for phenylketonuria: availability in Europe and an examination of their nutritional profile Maria Pena, Manuela Almeida, Esther van Dam, Orphanet Journal of Rare Diseases	2015	55
Urea cycle disorders in Spain: an observational, cross-sectional and multicentric study of 104 cases Elena Martín‐Hernández, Luis Aldámiz‐Echevarría, E. Castejón-Ponce, Orphanet Journal of Rare Diseases	2014	49
The impact of COVID-19 pandemic on the diagnosis and management of inborn errors of metabolism: A global perspective Mohamed A. Elmonem, Amaya Bélanger-Quintana, Andrea Bordugo, Molecular Genetics and Metabolism Inborn ErrorsGlobal HealthCovid-19 PandemicInternational HealthCovid-19 Epidemiology	2020	45
Protein substitutes for phenylketonuria in Europe: access and nutritional composition Maria Pena, Manuela Almeida, Esther van Dam, European Journal of Clinical Nutrition NutritionUrologyBiochemistryMedicineClinical Nutrition	2016	43
Management of adult patients with phenylketonuria: survey results from 24 countries Friedrich K. Trefz, Francjan J. van Spronsen, Anita MacDonald, European Journal of Pediatrics Renal CareUrologyAdult PatientsChronic Kidney DiseaseGeriatric Urology	2014	42
Overweight and obesity in PKU: The results from 8 centres in Europe and Turkey Hülya Gökmen Özel, Kirsten Ahring, Amaya Bélanger-Quintana, Molecular Genetics and Metabolism Reports	2014	42
Pathogenic variants of <i>DNAJC12</i> and evaluation of the encoded cochaperone as a genetic modifier of hyperphenylalaninemia Diana Gallego, Fátima Leal, Alejandra Gámez, Human Mutation GeneticsGenetic EpidemiologyHuman PolymorphismMolecular BiologyPathology	2020	36

Page 1